Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Trade Expert: New TPP Deal A Missed Opportunity For US

November 24, 2017, Medtech Insight

Gina Vetere is quoted in a Medtech Insight article regarding what the new version of the Trans-Pacific Partnership (TPP) means for American manufacturers. According to Vetere, "With the U.S. not being part of that trade agreement, the challenge is that we've lost that opportunity to help set some of those rules that are so important, particularly for our innovative companies, including in the medical innovation industry." She adds, "We now have an agreement where the U.S. is no longer at the table setting the standards and rules that promote an innovative economy. The countries remaining at the table sent a message that they don't value the same rules U.S. innovators do, and I think it's unfortunate we missed that opportunity."

Share this article: